PanGIA Biotech, Inc.
PrivateLast Round
Convertible Debt
May 11, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PanGIA Biotech, Inc. is a biotechnology company that develops an AI-integrated, urine- and CSF-based liquid biopsy platform for the non-invasive detection of cancer and other complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PanGIA Biotech, Inc. Comparables
Compare PanGIA Biotech, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AOA Dx | 73% | |
| Caris Life Sciences | 72% | |
| MDxHealth | 70% | |
PanGIA Biotech, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | May 11, 2026 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
$1.58M raised in convertible debt.
- Oct 15, 2025
Grew 57% QoQ from 7 to 11 employees.
PanGIA Biotech, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PanGIA Biotech, Inc.'s valuation, stock price, and market status.